Nasdaq Most Active

Evommune, Inc.

Ticker: EVMN
Current Price: $7.63
% Daily Change: -4.86%
Volume (1,000s): 723.35
Average Volume (1,000s): 781.77
Market Cap (M): $315.50
1/2/2024 Price: $17.32
Change Since Inception: -55.95%
Updated at 9:33:08 AM EST
See full index: PRISM Biotech
Contact Information

Evommune, Inc.
1841 Page Mill Road
Suite 100
Palo Alto, CA 94304
United States

About Evommune, Inc.

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. It develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products includes EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.

Market Data

News

Next Up

November 13, 2026
Cerenome, Inc.
November 09, 2026
Vir Biotechnology, Inc.
November 03, 2026
SI-BONE, Inc.

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup